Trade Summary

2 days ago, Donovan Joanne M., serving as CMO at Edgewise Therapeutics, Inc. (EWTX), sold 55,230 shares at $37.88 per share, for a total transaction value of $2,092,063.00. Following this transaction, Donovan Joanne M. now holds 4,367 shares of EWTX.

This sale represents a 93.00% decrease in Donovan Joanne M.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 1 day after the trade was made.

Edgewise Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.